UBCare Co., Ltd. (KOSDAQ:A032620) agreed to acquire Brain Healthcare Co., Ltd. from Seungwon Park and Seungo Park for KRW 18.8 billion on March 8, 2018. As consideration, UBCare Co., Ltd. will pay KRW 3.2 billion in cash to Brain Healthcare Co., Ltd., KRW 9.3 billion in cash and treasury stock to Seungwon Park and KRW 6.2 billion in cash and treasury stock to Seungo Park. Under the transaction, UBCare Co., Ltd. will acquire 0.0074 million shares, 0.0021 million shares, 0.0014 million shares at KRW 435,096 per share from Brain Healthcare Co., Ltd, Seungwon Park and Seungo Park respectively. The consideration of KRW 11.1 billion shall be paid within seven days from the date of the stock acquisition, KRW 2.5 billion shall be paid with the treasury stock held by UBCare Co., Ltd. and remaining KRW 1.9 billion shall be paid within 3 months. Brain Healthcare Co., Ltd. issued 0.044 million as new shares for the transaction. The acquisition of new shares was completed on March 8, 2018. As of March 9, 2018, KRW 11.13 billion was paid. The treasury shares for KRW 2.5 billion will be paid within seven days from March 8, 2018, cash of KRW 11.13 billion within seven days from March 8, 2018, and balance of KRW 1.88 billion within three months from March 8, 2018. The transaction has been resolved by the Board of UBCare Co., Ltd. The transaction is expected to be completed by June 7, 2018. As of June 7, 2018, the terms were revised. Now, a total consideration of KRW 18.56 billion will be paid, out of which new shares will be acquired for KRW 435,096 and Seungwon Park and Seungo Park will be paid in cash of KRW 12.82 billion and shares of KRW 2.5 billion.